levamisole has been researched along with Emesis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mallik, S; Mishra, P; Ojha, P; Palaian, S | 1 |
| Broun, G; Comas, F; Gordon, D; Krauss, S; Mendiondo, O; Mill, W; Perez, C; Philpott, G; Robbins, R; Smalley, R | 1 |
| Creagan, ET; Kardinal, CG; Maples, WJ; Marks, RS; Marschke, RF; Rowland, KM; Suman, VJ | 1 |
| Bagniewski, PG; Kovach, JS; Moertel, CG; O'Connell, MJ; Reid, JM | 1 |
3 trial(s) available for levamisole and Emesis
| Article | Year |
|---|---|
Treatment of inoperable non-small cell carcinoma of the lung with radiation therapy, with or without levamisole. A randomized trial of the Southeastern Cancer Study group.
Topics: Adenocarcinoma; Agranulocytosis; Carcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Humans; Levamisole; Lung Neoplasms; Nausea; Placebos; Propionibacterium acnes; Radiotherapy Dosage; Random Allocation; Time Factors; Vomiting | 1984 |
Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma.
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Aged; Confidence Intervals; Disease Progression; Female; Humans; Immunotherapy, Adoptive; Injections, Subcutaneous; Interleukin-2; Killer Cells, Lymphokine-Activated; Levamisole; Male; Melanoma; Middle Aged; Pain; Recombinant Proteins; Remission Induction; Sleep Stages; Survival Rate; Treatment Outcome; Treatment Refusal; Vomiting | 1997 |
Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Confusion; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Humans; Injections, Intravenous; Levamisole; Male; Middle Aged; Neoplasms; Treatment Outcome; Vertigo; Vomiting | 1998 |
1 other study(ies) available for levamisole and Emesis
| Article | Year |
|---|---|
Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in Nepal.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Female; Hospital Bed Capacity, 500 and over; Hospitals, Teaching; Humans; Length of Stay; Levamisole; Male; Middle Aged; Nausea; Neoplasms; Nepal; Neutropenia; Retrospective Studies; Sex Factors; Vomiting | 2007 |